Thomson DB - Search Results

1

Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial.

Thomson DB, Adena M, McLeod GR, Hersey P, Gill PG, Coates AS, Olver IN, Kefford RF, Lowenthal RM, Beadle GF, et al. Thomson DB, et al. Melanoma Res. 1993 Apr;3(2):133-8. Melanoma Res. 1993. PMID: 8518552 Clinical Trial.

2

Clinical evaluation of interferons in malignant melanoma.

McLeod GR, Thomson DB, Hersey P. McLeod GR, et al. Among authors: thomson db. J Invest Dermatol. 1990 Dec;95(6 Suppl):185S-187S. doi: 10.1111/1523-1747.ep12875500. J Invest Dermatol. 1990. PMID: 1701806 Free article. Review.

3

Treatment of advanced malignant melanoma with recombinant interferon alfa-2a in combination with DTIC: long-term follow-up of two phase II studies.

Hersey P, McLeod GR, Thomson DB. Hersey P, et al. Among authors: thomson db. Br J Haematol. 1991 Oct;79 Suppl 1:60-6. doi: 10.1111/j.1365-2141.1991.tb08122.x. Br J Haematol. 1991. PMID: 1931712

4

Recombinant interferon-alpha2a plus 5-fluorouracil for the treatment of metastatic melanoma.

Walpole ET, Hersey P, Thomson D, McLeod GR. Walpole ET, et al. Melanoma Res. 1997 Dec;7(6):513-6. doi: 10.1097/00008390-199712000-00011. Melanoma Res. 1997. PMID: 9464625 Clinical Trial.

5

Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma.

Coates A, Thomson D, McLeod GR, Hersey P, Gill PG, Olver IN, Kefford R, Lowenthal RM, Beadle G, Walpole E. Coates A, et al. Eur J Cancer. 1993;29A(12):1731-4. doi: 10.1016/0959-8049(93)90115-v. Eur J Cancer. 1993. PMID: 8398303 Clinical Trial.

6

Recombinant interferon alfa-2a in advanced malignant melanoma. A phase I-II study in combination with DTIC.

McLeod GR, Thomson DB, Hersey P. McLeod GR, et al. Among authors: thomson db. Int J Cancer Suppl. 1987;1:31-5. doi: 10.1002/ijc.2910390707. Int J Cancer Suppl. 1987. PMID: 3476475

7

Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma.

Millward MJ, Joshua A, Kefford R, Aamdal S, Thomson D, Hersey P, Toner G, Lynch K. Millward MJ, et al. Invest New Drugs. 2005 Jun;23(3):253-6. doi: 10.1007/s10637-005-6734-z. Invest New Drugs. 2005. PMID: 15868382 Clinical Trial.

8

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.

Toner GC, Stockler MR, Boyer MJ, Jones M, Thomson DB, Harvey VJ, Olver IN, Dhillon H, McMullen A, Gebski VJ, Levi JA, Simes RJ. Toner GC, et al. Among authors: thomson db. Lancet. 2001 Mar 10;357(9258):739-45. doi: 10.1016/s0140-6736(00)04165-9. Lancet. 2001. PMID: 11253966 Clinical Trial.

9

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.

Grimison PS, Stockler MR, Thomson DB, Olver IN, Harvey VJ, Gebski VJ, Lewis CR, Levi JA, Boyer MJ, Gurney H, Craft P, Boland AL, Simes RJ, Toner GC. Grimison PS, et al. Among authors: thomson db. J Natl Cancer Inst. 2010 Aug 18;102(16):1253-62. doi: 10.1093/jnci/djq245. Epub 2010 Jul 14. J Natl Cancer Inst. 2010. PMID: 20631341 Clinical Trial.

10

Illusions in advanced cancer: the effect of belief systems and attitudes on quality of life.

Beadle GF, Yates PM, Najman JM, Clavarino A, Thomson D, Williams G, Kenny L, Roberts S, Mason B, Schlect D. Beadle GF, et al. Psychooncology. 2004 Jan;13(1):26-36. doi: 10.1002/pon.722. Psychooncology. 2004. PMID: 14745743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters